ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,486, issued on Feb. 17, was assigned to SHANGHAI AUSON PHARMACEUTICALS Co. LTD. (China).
"Rivaroxaban formulation" was invented by Peng Hou (Shanghai), Enxian Lu (East Brunswick, N.J.) and Tao Zhu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "This document discloses rivaroxaban tablets for oral suspension formulation for oral administration. Also disclosed is a method for preparing rivaroxaban tablets for oral suspension and a method of treating diseases."
The patent was filed on March 27, 2025, under Application No. 19/092,739.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/n...